Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 271 citing articles:

Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 799-815
Closed Access | Times Cited: 55
Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing
Xinyue Li, Yue Shen, Li Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188720-188720
Closed Access | Times Cited: 53
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
Sui Peng, Shuling Chen, Wei Hu, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 6, pp. 728-744
Open Access | Times Cited: 52
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy
Jiawei Shi, Junwei Liu, Xiaoxuan Tu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003133-e003133
Open Access | Times Cited: 50
An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis
Jiaheng Xie, Liang Chen, Qingmei Sun, et al.
Aging (2022) Vol. 14, Iss. 7, pp. 3276-3292
Open Access | Times Cited: 48
Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
Phuong H. D. Nguyen, Martin Wasser, Chong Teik Tan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
Yue Chen, Haoyue Hu, Xianglei Yuan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
Wei‐Feng Qu, Meng‐Xin Tian, Hongwei Lü, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 927-941
Open Access | Times Cited: 31
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 31
Spatial metabolomics and its application in the liver
André A. Santos, Teresa C. Delgado, Vanda Marques, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1158-1179
Open Access | Times Cited: 29
Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy
Xiaohua Xing, En Hu, Jiahe Ouyang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 12, pp. 101315-101315
Open Access | Times Cited: 24
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Kaina Chen, Timothy Wai Ho Shuen, Pierce K. H. Chow
British Journal of Cancer (2024) Vol. 131, Iss. 3, pp. 420-429
Open Access | Times Cited: 15
Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer
Ji Shi, Xu Zhu, Jun‐Bo Yang
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Closed Access | Times Cited: 1
Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies
N. de Vries, Ahmed Mahfouz, Frits Koning, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 58
Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
Dexi Zhou, Jiajie Luan, Cheng Huang, et al.
Gut and Liver (2020) Vol. 15, Iss. 4, pp. 500-516
Open Access | Times Cited: 52
The Current Landscape of Clinical Trials for Systemic Treatment of HCC
Friedrich Foerster, Peter R. Galle
Cancers (2021) Vol. 13, Iss. 8, pp. 1962-1962
Open Access | Times Cited: 49
Precision Oncology Beyond Genomics: The Future Is Here—It Is Just Not Evenly Distributed
Ulrike Pfohl, Alina Pflaume, Manuela Regenbrecht, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 928-928
Open Access | Times Cited: 45
Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study
Weiwei Zhai, Hannah Lai, Neslihan Arife Kaya, et al.
National Science Review (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 42
Multiomics technologies: role in disease biomarker discoveries and therapeutics
Mashooq Ahmad Dar, Azher Arafah, Kaisar Ahmad Bhat, et al.
Briefings in Functional Genomics (2022) Vol. 22, Iss. 2, pp. 76-96
Closed Access | Times Cited: 38
Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma
Katie E. Blise, Shamilene Sivagnanam, Grace L. Banik, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 35
Dietary folate drives methionine metabolism to promote cancer development by stabilizing MAT IIA
Jintao Li, Hai Zhen Yang, Mingzhu Lei, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Macrophages as key regulators of liver health and disease
Eleni Papachristoforou, Prakash Ramachandran
International review of cell and molecular biology (2022), pp. 143-212
Closed Access | Times Cited: 32
Hepatocellular Carcinoma: The Role of MicroRNAs
Sharad Khare, Tushar Khare, Raghu Ramanathan, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 645-645
Open Access | Times Cited: 29
Advances in Mass Spectrometry-Based Single Cell Analysis
Siheun Lee, Hung M. Vu, Jung‐Hyun Lee, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 395-395
Open Access | Times Cited: 22
Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
Zhijian Wang, Xuenuo Chen, Jia Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21

Scroll to top